Answers are grounded in this paper and cite their sources.
Sennoside-functionalized zirconium dioxide nanoparticles (Sen–ZrO₂ NPs) were engineered via a single-step green synthesis route using Cassia angustifolia leaf extract as both a bio reductant and stabilizer. Structural characterization confirmed phase-pure tetragonal ZrO₂ formation through X-ray diffraction (XRD), while Fourier-transform infrared spectroscopy (FTIR) verified sennoside anchoring via characteristic C O and O–H vibrations at 1680 cm⁻¹ and 3605 cm⁻¹. Scanning electron microscopy with energy-dispersive X-ray spectroscopy (SEM/EDS) revealed spherical morphologies with uniform elemental distribution. The Sen–ZrO₂ NPs exhibited pronounced Gram-selective antibacterial activity, demonstrating a fourfold potency enhancement against Staphylococcus aureus (MIC = 64 µg mL⁻¹) compared to unmodified ZrO₂. Time-kill assays further demonstrated a rapid 4-log reduction in bacterial viability within 6 h. Against MCF-7 breast cancer cells, the nanoparticles displayed dose-dependent cytotoxicity (IC₅₀ = 61.44 µg mL⁻¹), representing a 2.3-fold improvement over bare ZrO₂. This dual bioactivity is attributed to sennoside-mediated redox modulation and surface functionalization, which act synergistically to enhance membrane disruption and reactive oxygen species (ROS) generation. This work establishes a sustainable plant-engineered ZrO₂ nanoplatform with integrated antibacterial–anticancer functionality, presenting a viable green approach to advanced nanotherapeutics for combating antimicrobial resistance and cancer.
No takes yet. Share an insight, caveat, or question.
Jathar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: